EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HMB-Containing Oral Nutritional Supplementation and Mortality After Hip Fracture in Malnourished Older Adults: A Formulation-Specific Subanalysis of a Prospective Cohort

Francisco José Sánchez-Torralvo iD, Verónica Pérez-Del-Río iD, Luis Ignacio Navas Vela iD, María García-Olivares iD, Nuria Porras, Jose Abuín Fernández iD, Gabriel Olveira iD

Nutrients · 11.06.2026 · 18 (12) · 1891

DOI: 10.3390/nu18121891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.06.2026. Verfasst von Francisco José Sánchez-Torralvo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, 29007 Malaga, Spain. Hauptthemen laut MEDLINE: Hip Fractures, Malnutrition, Dietary Supplements, Valerates. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott (Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral nutritional supplementation (ONS) is commonly prescribed in malnourished older adults after hip fracture, but formulations are heterogeneous, and their comparative association with mortality remains unclear. We aimed to evaluate whether HMB-containing ONS was associated with lower mortality than non-HMB ONS and to explore whether supplement formulation combined with treatment persistence was associated with differential mortality patterns.

Methods

This was a formulation-specific subanalysis of a previously described prospective cohort of older adults with hip fracture and malnutrition or significant nutritional risk. Only patients with known ONS formulation were included (n = 107): 59 received HMB-containing ONS, and 48 received non-HMB ONS, including standard, diabetes-specific, and renal-oriented formulations. Mortality at 3, 6, and 12 months was analyzed using crude comparisons and multivariable logistic regression adjusted for sex, age, and Charlson comorbidity index. A 6-month adjusted Cox model was used as the main time-to-event analysis. Exploratory analyses assessed mortality according to supplement formulation and treatment persistence.

Results

Overall mortality was 14.0% at 3 months, 23.4% at 6 months, and 29.9% at 12 months. At 6 months, mortality was lower among patients receiving HMB-containing ONS than among those receiving non-HMB ONS (13.6% vs. 35.4%; p = 0.011), and the association remained significant after adjustment (OR 0.267; 95% CI 0.091–0.784; p = 0.016). Associations at 3 and 12 months were directionally consistent but not statistically significant. In the adjusted Cox model, prescription of HMB-containing ONS was associated with a lower hazard of death within 6 months (HR 0.358; 95% CI 0.145–0.885; p = 0.026). Exploratory analyses showed a 6-month mortality gradient according to formulation and persistence, ranging from 0.0% in patients receiving HMB-ONS for ≥3 months to 41.2% in those receiving non-HMB ONS for

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hip FracturesMalnutritionDietary SupplementsValeratesHumansFemaleMaleAgedAged, 80 and overProspective StudiesAdministration, OralNutritional StatusProportional Hazards ModelsTreatment Outcome

Stichwörter der Autor:innen

hip fracturemalnutritionmortalitynutritional supportolder adultsoral nutritional supplementstreatment persistenceβ-hydroxy-β-methylbutyrate

Substanzen

beta-hydroxyisovaleric acidValerates

Autor:innen und Institutionen

  • Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, 29007 Malaga, Spain.
  • Instituto de Investigación Biomédica de Málaga (IBIMA), Plataforma Bionand, 29010 Malaga, Spain.
  • Departamento de Medicina y Dermatología, Facultad de Medicina, University of Malaga, 29010 Malaga, Spain.
  • Unidad de Gestión Clínica de Cirugía Ortopédica y Traumatología, Hospital de la Axarquía, 29010 Malaga, Spain.
  • Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Torrecárdenas, 04009 Almería, Spain.
  • Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Francisco José Sánchez-Torralvo, Verónica Pérez-Del-Río, Luis Ignacio Navas Vela, María García-Olivares, Jose Abuín Fernández, Gabriel Olveira

Förderung

  • Abbott (Spain)

Zitieren

APA

Sánchez-Torralvo, F. J., Pérez-Del-Río, V., Navas Vela, L. I., García-Olivares, M., Porras, N., Fernández, J. A., & Olveira, G. (2026). HMB-Containing Oral Nutritional Supplementation and Mortality After Hip Fracture in Malnourished Older Adults: A Formulation-Specific Subanalysis of a Prospective Cohort. Nutrients, 18(12), 1891. https://doi.org/10.3390/nu18121891

Vancouver

Sánchez-Torralvo FJ, Pérez-Del-Río V, Navas Vela LI, García-Olivares M, Porras N, Fernández JA, et al. HMB-Containing Oral Nutritional Supplementation and Mortality After Hip Fracture in Malnourished Older Adults: A Formulation-Specific Subanalysis of a Prospective Cohort. Nutrients. 2026;18(12):1891. doi:10.3390/nu18121891

BibTeX
@article{SnchezTorralvo2026,
  author = {Sánchez-Torralvo, Francisco José and Pérez-Del-Río, Verónica and Navas Vela, Luis Ignacio and García-Olivares, María and Porras, Nuria and Fernández, Jose Abuín and Olveira, Gabriel},
  title = {HMB-Containing Oral Nutritional Supplementation and Mortality After Hip Fracture in Malnourished Older Adults: A Formulation-Specific Subanalysis of a Prospective Cohort},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1891},
  doi = {10.3390/nu18121891}
}
Kostenlos starten →